Alberto Repossini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alberto Repossini has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
Claudio Muneretto
Department of Cardiac Surgery, University of Brescia, Brescia, Italy
8 shared publicationsLorenzo Di Bacco
Department of Cardiac Surgery, University of Brescia, Brescia, Italy
6 shared publicationsAntonio Saino
4 shared publicationsBruno Passaretti
Department of Cardiology, Clinica Humanitas Gavazzeni, Bergamo, Italy
4 shared publications- Gianluigi Bisleri
Structural Heart Program, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
4 shared publications Laura Giroletti
Clinical Department of Cardiovascular Surgery, University of Brescia, Brescia, Italy
4 shared publications
Latest Publications
- 1 July 2019
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 158 (1) , 127-138.e1
Minimally invasive coronary artery bypass: Twenty-year experience
- 1 July 2019
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 158 (1) , 127-138.e1
Minimally invasive coronary artery bypass: Twenty-year experience
- 1 March 2018
- Published by Edizioni Minerva Medica in Minerva Cardiology and Angiology
- Vol. 66 (2) , 180-190
Stentless sutureless and transcatheter valves: a comparison of the hemodynamic performance of different prostheses concept
Article: Stentless sutureless and transcatheter valves: a comparison of the hemodynamic performance of different prostheses concept - Minerva Cardioangiologica 2018 April;66(2):180-90 - Minerva Medica - Journals
- 1 March 2018
- Published by Edizioni Minerva Medica in Minerva Cardiology and Angiology
- Vol. 66 (2) , 180-190
Stentless sutureless and transcatheter valves: a comparison of the hemodynamic performance of different prostheses concept
Article: Stentless sutureless and transcatheter valves: a comparison of the hemodynamic performance of different prostheses concept - Minerva Cardioangiologica 2018 April;66(2):180-90 - Minerva Medica - Journals
- 1 March 2017
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 153 (3) , 549-558.e3
Early hemodynamics and clinical outcomes of isolated aortic valve replacement with stentless or transcatheter valve in intermediate-risk patients
- 1 March 2017
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 153 (3) , 549-558.e3
Early hemodynamics and clinical outcomes of isolated aortic valve replacement with stentless or transcatheter valve in intermediate-risk patients
- 1 December 2016
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 102 (6) , 1956-1965
Pericardial Stentless Valve for Aortic Valve Replacement: Long-Term Results
- 1 December 2016
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 102 (6) , 1956-1965
Pericardial Stentless Valve for Aortic Valve Replacement: Long-Term Results
- Open Access
- 1 October 2016
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 4 (S1) , S52
Hybrid approach to multivessel coronary artery disease: a commentary
Hybrid approach to multivessel coronary artery disease: a commentary
- 1 October 2016
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 4 (S1) , S52
Open AccessHybrid approach to multivessel coronary artery disease: a commentary
Hybrid approach to multivessel coronary artery disease: a commentary
- 1 September 2015
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 100 (3) , 1094-1096
Chest Blunt Trauma: An Uncommon Cause of Aortic Stentless Bioprosthesis Dysfunction
- 1 September 2015
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 100 (3) , 1094-1096
Chest Blunt Trauma: An Uncommon Cause of Aortic Stentless Bioprosthesis Dysfunction
- 20 June 2015
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 49 (3) , 1020
Freedom SOLO: avoiding pitfalls to avoid premature failures?
- 20 June 2015
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 49 (3) , 1020
Freedom SOLO: avoiding pitfalls to avoid premature failures?
- 1 November 2014
- Vol. 23 (6) , 777-82
Platelet activation after sorin freedom solo valve implantation: a comparative study with Carpentier-Edwards Perimount Magna.
As platelet activation is known to be a side effect of cardiac surgery, recent analyses have been conducted to identify the association between thrombocytopenia and aortic valve replacement (AVR) using a bioprosthesis. The type of bioprosthesis has been indicated as an independent risk factor for a lower postoperative platelet count, an association which has been mainly observed with the Sorin Freedom Solo valve. The study aim was to analyze platelet activation after AVR with two different bioprostheses, the Sorin Freedom SOLO (FS) and the Carpentier-Edwards Magna (CE). Thirty-eight consecutive patients undergoing aortic valve surgery were enrolled prospectively and assigned to either the FS group (n = 18) or the CE group (n = 20) according to their clinical evaluation. Five patients who underwent isolated coronary artery bypass graft (CABG) with cardiopulmonary bypass (CPB) were included as a control group. Clinical biochemical parameters (von Willebrand factor (vWF), prothrombin fragments 1+2 (F1+2), P-selectin, and beta-thromboglobulin (beta-TG)) were assessed preoperatively (TO), and at 1 h (T1), 48 h (T2) and seven days (T3) postoperatively. The two groups differed in terms of age (FS 77.3 +/- 7.0 years; CE 65.4 +/- 8.4 years; p < 0.05). Intraoperatively, parameters such as CPB time (FS 106.8 +/- 25.5 min; CE 108.2 +/- 23.4 min, p = NS) and aortic cross-clamp time (FS 78.1 +/- 22.8 min; CE 80.7 +/- 19.4 min, p = NS) were comparable. The platelet count was significantly reduced after FS implantation compared to the other groups. Factors involving platelet activation and blood coagulation activation assessed by means of prothrombin F1+2 (FS: TO = 0.48; T1 = 0.66; T2 = 0.46; T3 = 0.52 nmol/ml versus CE: T0 = 0.38; T1 = 0.68; T2 = 0.41; T3 = 0.49 nmol/ml); P-selectin (FS: T0 = 89.6; T1= 130.4; T2 = 92.6; T3 = 94.3 ng/ml versus CE: T0 = 81.4; T1 = 115.9; T2 = 92.2; T3 = 85.7 ng/ml); and beta-TG (FS: T0 = 6.7; T1 = 17.6; T2 = 8.6; T3 = 7.7 ng/ml versus CE: T0 = 7.1; T1 = 15.6; T2 = 9,1; T3 = 7.5 ng/ml) were not significantly different. The previously described phenomenon of enhanced platelet reduction shortly after valve implantation in the FS group compared to another bioprosthesis is likely to be confirmed, but platelet activation should not be considered as the underlying mechanism. Superior (but not significant) preoperative values of biochemical parameters were found in FS versus CE patients, influencing postoperative levels without any variation in the trend pattern. The type of bioprosthesis implanted appeared not to influence platelet and blood coagulation activation.
- 1 November 2014
- Vol. 23 (6) , 777-82
Platelet activation after sorin freedom solo valve implantation: a comparative study with Carpentier-Edwards Perimount Magna.
As platelet activation is known to be a side effect of cardiac surgery, recent analyses have been conducted to identify the association between thrombocytopenia and aortic valve replacement (AVR) using a bioprosthesis. The type of bioprosthesis has been indicated as an independent risk factor for a lower postoperative platelet count, an association which has been mainly observed with the Sorin Freedom Solo valve. The study aim was to analyze platelet activation after AVR with two different bioprostheses, the Sorin Freedom SOLO (FS) and the Carpentier-Edwards Magna (CE). Thirty-eight consecutive patients undergoing aortic valve surgery were enrolled prospectively and assigned to either the FS group (n = 18) or the CE group (n = 20) according to their clinical evaluation. Five patients who underwent isolated coronary artery bypass graft (CABG) with cardiopulmonary bypass (CPB) were included as a control group. Clinical biochemical parameters (von Willebrand factor (vWF), prothrombin fragments 1+2 (F1+2), P-selectin, and beta-thromboglobulin (beta-TG)) were assessed preoperatively (TO), and at 1 h (T1), 48 h (T2) and seven days (T3) postoperatively. The two groups differed in terms of age (FS 77.3 +/- 7.0 years; CE 65.4 +/- 8.4 years; p < 0.05). Intraoperatively, parameters such as CPB time (FS 106.8 +/- 25.5 min; CE 108.2 +/- 23.4 min, p = NS) and aortic cross-clamp time (FS 78.1 +/- 22.8 min; CE 80.7 +/- 19.4 min, p = NS) were comparable. The platelet count was significantly reduced after FS implantation compared to the other groups. Factors involving platelet activation and blood coagulation activation assessed by means of prothrombin F1+2 (FS: TO = 0.48; T1 = 0.66; T2 = 0.46; T3 = 0.52 nmol/ml versus CE: T0 = 0.38; T1 = 0.68; T2 = 0.41; T3 = 0.49 nmol/ml); P-selectin (FS: T0 = 89.6; T1= 130.4; T2 = 92.6; T3 = 94.3 ng/ml versus CE: T0 = 81.4; T1 = 115.9; T2 = 92.2; T3 = 85.7 ng/ml); and beta-TG (FS: T0 = 6.7; T1 = 17.6; T2 = 8.6; T3 = 7.7 ng/ml versus CE: T0 = 7.1; T1 = 15.6; T2 = 9,1; T3 = 7.5 ng/ml) were not significantly different. The previously described phenomenon of enhanced platelet reduction shortly after valve implantation in the FS group compared to another bioprosthesis is likely to be confirmed, but platelet activation should not be considered as the underlying mechanism. Superior (but not significant) preoperative values of biochemical parameters were found in FS versus CE patients, influencing postoperative levels without any variation in the trend pattern. The type of bioprosthesis implanted appeared not to influence platelet and blood coagulation activation.
- 1 August 2014
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 98 (2) , 574-581
Hybrid Coronary Revascularization in 100 Patients With Multivessel Coronary Disease
- 1 August 2014
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 98 (2) , 574-581
Hybrid Coronary Revascularization in 100 Patients With Multivessel Coronary Disease